Have a personal or library account? Click to login
Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis Cover

Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis

Open Access
|Dec 2024

Figures & Tables

Figure 1.

Flow diagram of the literature selection process.
Flow diagram of the literature selection process.

Figure 2.

Meta-analysis and forest plot of post-RFA and pre-RFA of PTH levels. (A) 1 d, (B) 6 months, and (C) 12 months. PTH, parathyroid hormone; RFA, radiofrequency ablation.
Meta-analysis and forest plot of post-RFA and pre-RFA of PTH levels. (A) 1 d, (B) 6 months, and (C) 12 months. PTH, parathyroid hormone; RFA, radiofrequency ablation.

Figure 3.

Meta-analysis and forest plot of post-RFA and pre-RFA of serum calcium levels. (A) 1 d and (B) 6 months. RFA, radiofrequency ablation.
Meta-analysis and forest plot of post-RFA and pre-RFA of serum calcium levels. (A) 1 d and (B) 6 months. RFA, radiofrequency ablation.

Figure 4.

The meta-analysis, funnel plot, and forest plot of post-RFA and pre-RFA of serum phosphorus levels. (A) 1 d and (B) 6 months. RFA, radiofrequency ablation.
The meta-analysis, funnel plot, and forest plot of post-RFA and pre-RFA of serum phosphorus levels. (A) 1 d and (B) 6 months. RFA, radiofrequency ablation.

Combined data of side effects

ChenRenZhangQinTotal
Hoarseness2/146/479/3217/93 (18.3%)
Hypercalcemia4/1426/4730/61 (49.2%)
RLN injury5/302/97/39 (17.9%)

Quality assessment of cohort studies

ReferenceIs the case definition adequate?Representativeness of the casesSelection of controlsDefinition of controlsComparability of cases and controls on the basis of the design or analysisAscertainment of exposureSame method of ascertainment for cases and controlsNonresponse rateTotal scores
Chen et al., [36]8
Ren et al., [37]7
Zhang et al., [38]7
Qin et al., [39]8

Basic information of the included studies

ReferenceCountryInstitutionDesignSample sizeGender (male/female)Mean age (years)Follow-up period (months)Conducted periodFollow-up time point (d/months)Complications (N)
Chen et al., [36]Taiwan, ChinaThe Kaohsiung Chang Gung Memorial Hospital Medical Center in TaiwanRetrospective study96/351.80 ± 16.00122019.04–2020.12
  • 1 month

  • 3 months

  • 6 months

  • 12 months

  • Hoarseness (2)

  • Neck pain (4)

Ren et al., [37]ChinaZhejiang Provincial People's HospitalRetrospective study4729/1851 ± 1228.6 (21.3–36.6)2014.06–2020.12
  • 1 month

  • 3 months

  • 6 months

  • 12 months

  • 24 months

  • Hoarseness (6)

  • Hematoma (1)

  • Fever/infection (3)

  • Hypocalcemia (26)

  • Severe hypocalcemia (6)

Zhang et al., [38]ChinaFujian Provincial HospitalRetrospective study3016/1445.8 ± 13.362018.01–2021.02
  • 1 d, 7 d

  • 1 month

  • 3 months

  • 6 months

  • Recurrence (7)

  • Recurrent laryngeal nerve injury (8)

  • Severe hypocalcemia (6)

Qin et al., [39]ChinaNanchong Central HospitalRetrospective study3213/1953.53 ± 13.64122018.11–2019.05
  • 1 d, 2 d

  • 6 months

  • 12 months

  • Hoarseness (9)

  • Neck pain (1)

  • Artery injury (1)

Publication bias analyses were performed using Egger's test

OutcomesFollow-up time pointtP
Serum PTH1 d−1.3130.320
6 months−0.8190.499
12 months−0.8490.552
Serum calcium1 d−1.9420.192
6 months−0.5770.622
Serum phosphorus1 d−0.6520.632
6 months−0.2190.863
DOI: https://doi.org/10.2478/abm-2024-0036 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 287 - 296
Published on: Dec 16, 2024
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2024 Mengyuan Li, Hongwei Jiang, Yunchang Wang, Fujun Li, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.